Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study.
Saved in:
| Title: | Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study. |
|---|---|
| Authors: | Huhn GD; Ruth M. Rothstein CORE Center, Chicago, Illinois, USA., Crofoot G; Crofoot Research Center, Houston, Texas, USA., Ramgopal M; Midway Immunology and Research Center, Fort Pierce, Florida, USA., Gathe J; Therapeutic Concepts, Houston, Texas, USA., Bolan R; Los Angeles LGBT Center, Los Angeles, California, USA., Luo D; Janssen Research & Development, LLC, Titusville, New Jersey, USA., Simonson RB; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA., Nettles RE; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA., Benson C; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA., Dunn K; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Dec 15; Vol. 71 (12), pp. 3110-3117. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
